Small bowel distension

w.ajaj's picture

Dose Optimization of Mannitol Solution For Small Bowel Distension In MRI

Journal Title, Volume, Page: 
JOURNAL OF MAGNETIC RESONANCE IMAGING 20:648–653 (2004)
Year of Publication: 
2004
Authors: 
Waleed Ajaj
Department of Diagnostic and Interventional Radiology, University Hospital Essen, Essen, Germany
Current Affiliation: 
Department of Medicine, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine
Susanne C. Goehde
Department of Diagnostic and Interventional Radiology, University Hospital Essen, Essen, Germany
Hubert Schneemann
Institute of Pharmacy and Pharmaceutical Sciences, University Hospital Essen, Essen, Germany
Stefan G. Ruehm
Department of Radiology, David Geffen School of Medicine at UCLA, Los Angeles, California
Jorg F. Debatin
Department of Diagnostic and Interventional Radiology, University Hospital Essen, Essen, Germany
Thomas C. Lauenstein
Department of Diagnostic and Interventional Radiology, University Hospital Essen, Essen, Germany
Preferred Abstract (Original): 

Purpose: To optimize the dose of a hydro solution containing 2.5% mannitol and 0.2% locust bean gum (LBG) for small bowel MRI in terms of bowel distension and patient acceptance.
Materials and Methods: A total of 10 healthy volunteers ingested a hydro solution containing 2.5% mannitol and 0.2% LBG. Four different volumes (1500, 1200, 1000, and 800 ml) were assessed on four different examination days. Small bowel distension was quantified on coronal two-dimensional TrueFISP images by measuring the diameter of eight bowel loops throughout the jejunum and the ileum. In addition, volunteer acceptance was evaluated for every single examination by using a questionnaire.
Results: Optimal distension was obtained with either, 1000, 1200, or 1500 ml, with no statistically significant differences in distension between these groups. Administration of 800 ml led to significantly less distension of the small bowel. Significantly less side effects were noted using either 800 or 1000 ml compared to using larger volumes.
Conclusion: We recommend a dose of 1000 ml mannitol/ LBG solution as an oral contrast agent for optimal bowel distension and minimal side effects.

w.ajaj's picture

Oral Contrast Agents For Small Bowel Distension In MRI: Influence of The Osmolarity For Small Bowel Distention

Journal Title, Volume, Page: 
European Radiology (2005) Volume: 15, Issue: 7, Pages: 1400-1406
Year of Publication: 
2005
Authors: 
Waleed Ajaj
Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Hufelandstrasse 55, 45122, Essen, Germany
Current Affiliation: 
Department of Medicine, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine
Mathias Goyen
Medical Center Hamburg-Eppendorf, Hamburg, Germany
Hubert Schneemann
Institute of Pharmacy and Pharmaceutical Sciences University Hospital Essen, Essen, Germany
Christiane Kuehle
Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Hufelandstrasse 55, 45122, Essen, Germany
Michael Nuefer
Department of Diagnostic and Interventional Radiology and Neuroradiology University Hospital Essen, Hufelandstrasse 55, 45122 Essen, Germany
Stefan G. Ruehm
Geffen School of Medicine at UCLA, Los Angeles, CA, USA
Susanne C. Goehde
Department of Diagnostic and Interventional Radiology and Neuroradiology University Hospital Essen, Hufelandstrasse 55, 45122 Essen, Germany
Thomas C. Lauenstein
Department of Diagnostic and Interventional Radiology and Neuroradiology University Hospital Essen, Hufelandstrasse 55, 45122 Essen, Germany
Preferred Abstract (Original): 

To assess the effect of the osmolarity for small bowel distension in MRI, ten volunteers ingested at two separate occasions negative oral contrast agents with different quantity and osmolarity: (1) a water solution combined with 2.0% sorbitol and 0.2% locus bean gum (LBG) with a quantity of 1500 ml and an osmolarity of 148 mOsmol/l, (2) a water solution combined with 2.0% sorbitol and 2.0% barium sulphate with a quantity of 1000 ml and an osmolarity of 194 mOsmol/l. Small bowel distension was quantified on coronal 2D-TrueFISP images by measuring the small bowel diameters. There were no statistically significant differences in mean small bowel diameter between both contrast agents. The mean small bowel distension was 19.2 mm after ingestion of 1500 ml of sorbitol-LBG solution and 19.0 mm after ingestion of 1000-ml sorbitol-barium sulphate solution. Furthermore, all volunteers found the ingestion of 1000-ml solution more pleasant than the 1500-ml solution. The ingestion of 1000 ml of sorbitol-barium sulphate solution led to a sufficient small bowel distension compared to 1500 ml of sorbitol-LBG solution. The side effect rate of both solutions was low. Based on these data, we recommend a quantity of 1000 ml of sorbitol-barium sulphate solution as an alternative for 1500-ml sorbitol-LBG solution for optimal bowel distension.

Syndicate content